SNDX Dividend History & Analysis | N/A Yield
SNDX has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Biotechnology
| Symbol | Market Cap USD | Dividend Yield TTM | Yield on Cost 5y |
|---|---|---|---|
| BTX | 1,434 M | 13.6% | 7.37% |
| ABBV | 406,304 M | 3.59% | 9.40% |
| AMGN | 179,831 M | 3.65% | 6.13% |
| GILD | 155,932 M | 2.53% | 6.57% |
| HLN | 45,108 M | 1.74% | 2.46% |
| Symbol | Market Cap USD | Growth Rate (CAGR) | Payout Consistency |
|---|---|---|---|
| BTX | 1,434 M | 203% | 90.0% |
| GRFS | 7,645 M | 127% | 56.8% |
| HLN | 45,108 M | 51.0% | 100% |
| AMGN | 179,831 M | 8.90% | 100% |
| ABBV | 406,304 M | 7.06% | 100% |
Similar Stocks with Attractive Dividends - Compare SNDX Dividends with its Peer-Group
3.59% Yield
3.65% Yield
2.53% Yield
1.74% Yield
SNDX Dividend History: as of December 2025
No dividends paid yet.SNDX Dividend FAQ
Syndax Pharmaceuticals (NASDAQ:SNDX) is a commercial-stage biotech focused on oncology, with its lead candidates revumenib (a menin inhibitor) for relapsed/refractory acute leukemias and axatilimab (a CSF-1R antibody) for chronic graft-versus-host disease. The firm is expanding revumenib into mutant NPM1 AML, combination regimens, and metastatic colorectal cancer, while axatilimab is also being evaluated for idiopathic pulmonary fibrosis; it holds a licensing deal with Eddingpharm to develop the HDAC inhibitor entinostat.
What is the Dividend Yield of SNDX?
As of December 2025, SNDX`s dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 21.07.Does SNDX pay a dividend?
As of December 2025 SNDX does not pay a dividend.How often does SNDX pay dividends?
Over the last 12 months, SNDX has issued dividend payments.SNDX dividend forecast
Based on historical data, the forecasted dividends per share for SNDX for the next 4 payments are between 0 (+0.0%) and 0 (+0.0%).This suggests the dividend will remain relatively stable.
Will SNDX pay dividends in 2025?
The next Ex-Dividend date for Syndax Pharmaceuticals (SNDX) is currently unknown.What is the next Ex-Dividend Date for SNDX?
The next Ex-Dividend date for Syndax Pharmaceuticals (SNDX) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.What is the Dividend Growth of SNDX?
SNDX's average dividend growth rate over the past 5 years is -% per year.
What is the Yield on Cost of SNDX?
SNDX's 5-Year Yield on Cost is -%. If you bought SNDX's shares at 22.24 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.What is the Payout Consistency of SNDX?
SNDX Payout Consistency is 0.0%.
The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Does SNDX have a good Dividend Yield?
SNDX`s % Dividend Yield is considered as unknown.What is the Dividend Payout Ratio of SNDX?
The Dividend Payout Ratio of SNDX is unknown.What is the Dividend Rating of SNDX?
SNDX`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.Key Metric Definitions
- Dividend Yield: Annual dividend per share divided by current share price.
- Dividend Growth Rate: Compound annual growth rate of annual dividend per share over the last 5 years.
- Payout Ratio: Percentage of earnings paid as dividends (TTM).
- Payout Consistency: % of eligible periods with uninterrupted or increased dividends, measured over the entire lifetime of the stock or fund.
- Payout Frequency: Number of dividends paid in the last 12m (TTM).
- Overall Dividend Rating: Proprietary composite score, quantified on a scale from 0 to +100. Ratings surpassing 70 are regarded as favorable, while those exceeding 85 are strong.
- Total Return: Price appreciation plus dividends over specified period.
- Market Cap: Figures are in millions of the corresponding currency.
Last update: 2025-12-15 04:46